Adoptive immunotherapy using donor liver graft derived natural killer (NK) cells for preventing severe infection after liver transplantatio
Not Applicable
Recruiting
- Conditions
- decompensated liver cirrhosis patients who will receive liver transplantation
- Registration Number
- JPRN-UMIN000019183
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients who will receive re-transplantation 2) patients who will receive deceased donor liver transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of blood stream infection during one month after liver transplantation
- Secondary Outcome Measures
Name Time Method 1. Overall survival (6 months, 1 and 3 years) 2. Effect on immunological reaponse after liver transplantation 3. Incidence of recurrence of hepatocellular carcinoma and de novo malignancy 4. Incidence of other infectious disease 5. Safety evaluation